Clinical trial
Longitudinal Study of the in Vitro Action of Low Molecular Weight Heparin (LMWH) in Pregnant Women by Thrombinography
NCT06575309 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Study of the in Vitro Action of Low Molecular Weight Heparin (LMWH) in Pregnant Women by Thrombinography
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 22, 2024
- Completion date
- December 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
pregnant women, venous thromboembolic disease